Executive opportunityBG-US-CTO-03

Chief Technology Officer

AI Precision Medicine · Molecular Therapeutics · MedTech

Location

Washington, D.C.

Backing

High Net Worth investor funded

Compensation

US$250,000 base + equity + bonus

Travel

Extensive US travel

The opportunity

Blackgate has been exclusively retained by a High Net Worth investor to identify an exceptional CTO to help build one of the most ambitious AI-driven MedTech platforms currently in development. A founder-level appointment creating a proprietary platform that delivers personalised molecular treatment pathways through advanced AI and precision medicine.

The business

◦Combining AI, precision medicine and molecular treatment design.
◦Clinical decision support and healthcare analytics at the core.
◦Secure patient-data architecture as a first-class concern.
◦Privately funded and entering its execution phase post-investment.
◦Seeking a visionary technology leader for a globally scalable platform.

The role

◦Define the company's technology vision and build enterprise AI architecture.
◦Lead software engineering and design secure healthcare infrastructure.
◦Build cloud-native platforms and recruit world-class engineering teams.

The ideal candidate

◦Previous CTO or Founder CTO experience.
◦Strong AI architecture capability and machine-learning experience.
◦Experience building enterprise SaaS; healthcare or MedTech highly desirable.

Behind the gate

The full role, ideal-candidate profile, executive package and a direct introduction are reserved for Blackgate members. Membership is free and confidential.

About Blackgate

Blackgate is a specialist executive search and leadership advisory firm. We partner with private equity investors, boards and founders to identify leaders who create clarity, alignment and performance in complex environments. Every mandate is managed in the strictest confidence.